Tenta, R <br/><br/>
Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells.  [electronic resource] 

 -  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  Oct 2005 
 - 593-601 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0018-5043 
<br/><br/><label>Standard No.: </label>10.1055/s-2005-870525  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone and Bones--metabolism<br/>Cell Line, Tumor<br/>Dexamethasone--pharmacology<br/>Diphosphonates--pharmacology<br/>Fibroblast Growth Factor 2--metabolism<br/>Fluorescent Antibody Technique<br/>Growth Substances--metabolism<br/>Humans<br/>Imidazoles--pharmacology<br/>Insulin-Like Growth Factor I--metabolism<br/>Interleukin-6--metabolism<br/>Male<br/>Parathyroid Hormone-Related Protein--biosynthesis<br/>Prostatic Neoplasms--metabolism<br/>Receptor, Parathyroid Hormone, Type 1--biosynthesis<br/>Transforming Growth Factor beta--metabolism<br/>Zoledronic Acid